Aarti Pharmalabs News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Aarti Pharmalabs Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Aarti Pharmalabs Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Aarti Pharmalabs from all sources in a single place.

Aarti Pharmalabs Ltd.

22 Dec 2025

742.50

-2.28%

SAST

Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Aarti Pharmalabs Ltd.

17 Nov 2025

742.50

-2.28%

Earnings Call

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q2 FY 26 Earnings Conference Call.

pdf

Aarti Pharmalabs Ltd.

14 Nov 2025

742.50

-2.28%

Aarti Pharmalabs

Buy: Aarti Pharmalabs Ltd.

ICICI Direct

Capacity expansion across segments to steer growth beyond FY26Xanthine segment primarily witnessed the growth on account of capacity debottlenecking of ~1000 MTPA thereby taking overall capacity to 6000 MTPA from 5000 MTPA. The company remains on track to expand its capacity to 9000 MTPA by Q4FY26. Prices of xanthine remained stable, as per management. We believe APL to focus more on grabbing the larger wallet share across Pharma and beverage customers (higher margin opportunities). On the CDMO front, the management is confident of achieving its guidance of 30-40% growth on back of strong order book...

Number of FII/FPI investors increased from 133 to 140 in Sep 2025 qtr.

Aarti Pharmalabs Ltd.

11 Nov 2025

742.50

-2.28%

Company Update

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed

pdf

Aarti Pharmalabs Ltd.

11 Nov 2025

742.50

-2.28%

Investor Presentation

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for Q2 FY 26

pdf

Aarti Pharmalabs Ltd.

09 Nov 2025

742.50

-2.28%

Result

Aarti Pharmalabs Ltd - 543748 - Financial Results For Quarter And Half Year Ended September 30, …

BSE India

Please find enclosed.

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	418.39	387.79	462.51	7.9%	-9.5%
Operating Profit Qtr	74.72	95.24	93.67	-21.5%	-20.2%
Net Profit Qtr	27.92	49.50	54.62	-43.6%	-48.9%
Earning Per Share Adjusted latest Qtr	3.08	5.46	6.03	-43.6%	-48.9%

* Consolidated data

Detailed Results

Aarti Pharmalabs Ltd.

09 Nov 2025

742.50

-2.28%

Board Meeting

Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Board Meeting Outcome For Financial Results …

BSE India

Please find enclosed.

pdf

Aarti Pharmalabs Ltd.

09 Nov 2025

742.50

-2.28%

Board Meeting

Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Board Meeting Outcome For Financial Results …

BSE India

Please find enclosed.

pdf

Aarti Pharmalabs Ltd.

09 Nov 2025

742.50

-2.28%

Company Update

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Please find enclosed.

pdf

Aarti Pharmalabs Ltd.

04 Nov 2025

742.50

-2.28%

Company Update

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Tuesday, November 11, 2025 at 4:00 P.M. (IST) to discuss the Company''s Q2-FY26 Financial Results.

pdf

RESEARCH REPORTS

Buy SEE REPORTS >

pdf